Earnings Feed
Start Free
ANGIOTECH PHARMACEUTICALS INC·4

May 16, 4:59 PM ET

Diaz Victor Manuel 4

4 · ANGIOTECH PHARMACEUTICALS INC · Filed May 16, 2011

Insider Transaction Report

Form 4
Period: 2011-05-12
ANGIOTECH PHARMACEUTICALS INCANPI
Diaz Victor Manuel
Sr VP, Global Manufacturing
Transactions
  • Other

    Stock Option w/Tandem SAR

    2008-12-08−150,000→ 30,000 total
    Exercise: $0.16From: 2009-01-01Exp: 2013-12-07→ Common Stock (150,000 underlying)
  • Other

    Stock Option w/Tandem SAR

    2010-03-08−85,000→ 330,000 total
    Exercise: $1.05From: 2010-04-01Exp: 2015-03-07→ Common Stock (85,000 underlying)
  • Other

    Stock Option w/Tandem SAR

    2009-03-10−150,000→ 180,000 total
    Exercise: $0.27From: 2009-04-01Exp: 2014-03-09→ Common Stock (150,000 underlying)
  • Other

    Awards

    2008-03-31−30,000→ 0 total
    Exercise: $5.69From: 2007-05-01Exp: 2012-04-26→ Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT